19 reports

  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

Patients were randomized ##:##:##:## to receive ## mg of emricasan, ## mg of emricasan, ## mg of emricasan, or placebo twice daily for ## weeks.

  • Clinical Trial
  • Drug Development
  • Hypertension
  • World
  • Product Initiative

A. ## ##. ##. ## C O M P A N Y O V E R V I E W COMPANY HEADQUARTERS: GENTILLY, FRANCE FOUNDED: 2004 WORKFORCE: ##, ## EMPLOYEES (2016) Company Working: ## ##. ##. ## F I N A N C I A L O V E R V I E W Sales Revenue SANOFI S. A.

  • Hypertension
  • North America
  • United States
  • World
  • Forecast
  • OLIGONUCLEOTIDE TO INHIBIT MICRORNA-145 FOR PULMONARY ARTERIAL HYPERTENSION - DRUG PROFILE
  • PULMONARY ARTERIAL HYPERTENSION - PIPELINE BY CELTAXSYS INC, H1 2019

Patients will be randomized in a ##:##:## ratio (macitentan ##mg: macitentan ##mg: placebo).

  • Hypertension
  • Therapy
  • United States
  • Company
  • Product Initiative

The prominent features of this report are - ##.

  • Clinical Trial
  • Drug Development
  • Hypertension
  • World
  • Product Initiative
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Hypertension
  • Neurology
  • World
  • Product Initiative
  • AstraZeneca PLC
  • OLIGONUCLEOTIDE TO INHIBIT MICRORNA-145 FOR PULMONARY ARTERIAL HYPERTENSION - DRUG PROFILE
  • PULMONARY ARTERIAL HYPERTENSION - PIPELINE BY CAPRICOR THERAPEUTICS INC, H2 2018

PULMONARY ARTERIAL HYPERTENSION - PIPELINE BY CAPRICOR THERAPEUTICS INC, H## 2018 Celsion Corp (Celsion) is an oncology company that strives to develop a portfolio of new cancer treatments, including directed chemotherapies, RNA or DNA based therapies and immunotherapies.

  • Hypertension
  • Therapy
  • United States
  • Product Initiative
  • Actelion Ltd
  • 5. All the trials included are unique trials.

A total of ## patients will be randomized ##:##:## into three treatment arms with standardof-care vasodilator therapies in combination with sotatercept or placebo.

  • Cardiology
  • Clinical Trial
  • Hypertension
  • Therapy
  • World
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Cardiology
  • Chronic Disease
  • Clinical Trial
  • Hypertension
  • World
  • OLIGONUCLEOTIDE TO INHIBIT MICRORNA-145 FOR PULMONARY ARTERIAL HYPERTENSION - DRUG PROFILE
  • HYPERTENSION - PIPELINE BY MARINA BIOTECH INC, H1 2018

Ionis Pharmaceuticals Inc (Ionis) formerly ISIS Pharmaceuticals, Inc. focuses on the discovery and development of RNA-targeted drugs.

  • Hypertension
  • Therapy
  • Company
  • Product Initiative
  • Anavex Life Sciences Corp.
  • Clinical Trial Profile Snapshots

Novartis AG ## ## ## ## ## ## ## ## ## ## Genextra S. p. a. ## ## ## ## ## Dr.

  • Drug Development
  • Hospital
  • Hypertension
  • World
  • Product Initiative
  • HYPERTENSION - PIPELINE BY LIQUIDIA TECHNOLOGIES INC
  • PULMONARY ARTERIAL HYPERTENSION - PIPELINE BY CAPRICOR THERAPEUTICS INC

Patients were randomized ##:##:##:## to receive ## mg of emricasan, ## mg of emricasan, ## mg of emricasan, or placebo twice daily for ## weeks.

  • Chronic Disease
  • Hypertension
  • Company
  • Product Initiative
  • HanAll Biopharma Co., Ltd.
  • OLIGONUCLEOTIDE TO INHIBIT MICRORNA-145 FOR PULMONARY ARTERIAL HYPERTENSION - DRUG PROFILE
  • HYPERTENSION - PIPELINE BY INSYS THERAPEUTICS INC, H2 2017

It focuses on the discovery and development of RNA-targeted drugs.

  • Hypertension
  • Research And Development
  • United States
  • Company
  • Actelion Ltd

The prominent features of this report are - ##.

  • Chronic Disease
  • Hypertension
  • Neurology
  • World
  • Product Initiative

## ## ## ## ## ## ## ## ## ## ## ## ## ## ## IND ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## PC ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## P I ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ##

  • Chronic Disease
  • Genitourinary System Disease
  • Hypertension
  • United States
  • Product Initiative

Nine compounds have been awarded orphan drug status for PAH. ##. ## PIPELINE DRUGS BY PHASE TABLE ##: FIGURE ##: TABLE ##: ##. ## PIPELINE DRUGS BY COMPANY TABLE ##: (##) PULMONARY ARTERIAL HYPERTENSION PIPELINE BY COMPANIES, H##- 2018 TABLE ##: (##) PULMONARY ARTERIAL HYPERTENSION PIPELINE BY C

  • Chronic Disease
  • Hypertension
  • Pharmaceutical
  • Therapy
  • United States

The prominent features of this report are - ##.

  • Cardiology
  • Clinical Trial
  • Hypertension
  • Pharmaceutical
  • World

Oxazolidinones target DNA gyrase and bacterial ##S ribosomal RNA.

  • Hypertension
  • Therapy
  • United States
  • Company Operations
  • Actelion Ltd

The prominent features of this report are - ##.

  • Cardiology
  • Drug Development
  • Hypertension
  • World
  • Product Initiative

Genes involved in inflammatory response, antibacterial response, and innate immunity were assessed by RT-PCR RNA-array from ileum.

  • Digestive System Disorder
  • Hypertension
  • Therapy
  • United States
  • Product Initiative